Helius Medical Technologies, Inc. (HSDT)
| Market Cap | 34.61M |
| Revenue (ttm) | 477,000 |
| Net Income (ttm) | -15.36M |
| Shares Out | 2.32M |
| EPS (ttm) | -8.68 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,408 |
| Open | 14.30 |
| Previous Close | 14.12 |
| Day's Range | 13.67 - 14.48 |
| 52-Week Range | 11.00 - 600.25 |
| Beta | 0.84 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings Date | n/a |
About HSDT
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic e...
Financial Performance
In 2020, HSDT's revenue was $661,000, a decrease of -55.82% compared to the previous year's $1.50 million. Losses were -$14.13 million, 44.5% more than in 2019.
Financial StatementsNews
Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference
NEWTOWN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that ...
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors
NEWTOWN, Pa., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced the ap...
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
NEWTOWN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange
NEWTOWN, Pa., Aug. 25, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...
New Strong Sell Stocks for August 20th
ADXN, CSSE, HSDT, LYRA, and TRVN have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2021.
Helius Medical's Neuromodulation Stimulator Nabs FDA Breakthrough Tag
The FDA has granted Breakthrough Device Designation to Helius Medical Technologies Inc's (NASDAQ:HSDT) PoNS device. Related content: Benzinga's Full FDA Calendar.
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and...
NEWTOWN, Pa., Aug. 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Lags Revenue Estimates
Helius Medical Technologies, Inc. (HSDT) delivered earnings and revenue surprises of -68.63% and -21.11%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for ...
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT ) (TSX: HSM ) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today ann...
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians
NEWTOWN, Pa., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...
Will Helius Medical Technologies, Inc. (HSDT) Report Negative Earnings Next Week? What You Should Know
Helius Medical Technologies, Inc. (HSDT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July
NEWTOWN, Pa., July 12, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer
NEWTOWN, Pa., July 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...
Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Th...
Company Selected to Receive the “Pioneer in Technology Award” Company Selected to Receive the “Pioneer in Technology Award”
Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021
NEWTOWN, Pa., June 30, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...
Helius Medical Technologies, Inc. to Participate in Noble Capital Markets' Virtual Road Show Series
NEWTOWN, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM), (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...
Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America
NEWTOWN, Pa., June 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...
Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results
NEWTOWN, Pa., May 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported...
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st
NEWTOWN, Pa., April 15, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021
NEWTOWN, Pa., April 07, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device
First and only tongue-delivered neuromodulation therapy provides new treatment option for U.S. patients living with gait deficit due to symptoms from multiple sclerosis First and only tongue-delivered n...
Helius Medical Technologies, Inc. to Present at the Investor Summit Group's Q1 Virtual Summit on March 23rd
NEWTOWN, Pa., March 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...
Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors
NEWTOWN, Pa., March 17, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announ...
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results
NEWTOWN, Pa., March 10, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today report...
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021
NEWTOWN, Pa., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announc...